Motomi OSATO

Osato has been studying the molecular mechanism of leukemogenesis by RUNX and related genes, using cell biological approaches, in vivo mouse and zebrafish systems and analysis of human leukemia samples. His current interest is to develop a novel treatment for Runx leukemia. He is also searching for cis-regulatory non-coding genomic elements associated with human leukemia and stem cells. His best known research accomplishment is the detection of point mutations in the RUNX1/AML1 gene in acute myeloid leukemia patients.

Principal Investigator, Cancer Science Insitute of Singapore, National University of Singapore
Principal Associate, Cancer Science Institute of Singapore, National University of Singapore
Research Associate Professor, Department of Pediatrics, Yong Loo Lin School of Medicine, National University of Singapore
Professor, International Research Center for Medical Sciences, Kumamoto University, Japan

Year(s) Degree (if applicable) Institute
1990 MD Oita Medical University, Japan
1999 Ph.D Graduate School of Medicine, Kumamoto University, Japan
2015 – present Professor, International Research Centre for Medical Science, Kumamoto University
2013 – present Research Associate Professor, Department of Pediatrics, Yong Loo Lin School of Medicine, NUS
2009 – present Clinician Scientist, Institute of Bioengineering and Nanotechnology, A*STAR
2008 – present Principal Associate, Cancer Science Institute of Singapore, NUS
2002 – 2008 Research Assistant Professor, Institute for Molecular and Cell Biology, A*STAR
1997 – 2002 Research Fellow & Instructor, Institute for Virus Research, Kyoto University, Japan